Summary

Global Intraoperative Neuromonitoring market is valued approximately at USD 5.09 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2024-2032. Intraoperative Neuromonitoring (IONM) is a crucial medical technique that ensures the integrity of the nervous system during surgical procedures by providing real-time feedback on neural pathways. This method employs various advanced technologies, including electrodes and sensors, to monitor neural activity, enhancing surgical precision and patient safety. The increasing geriatric population, along with the prevalence of diseases such as cardiovascular conditions, cancer, and osteoarthritis, significantly propels the demand for IONM. As the aging population grows, the incidence of these diseases is correspondingly soaring, which, in turn, necessitating accurate diagnostic and treatment methods where IONM plays a pivotal role.
Continuous advancements in IONM technologies, such as improved electrodes, real-time data analysis, and advanced signal processing, drive market growth by enhancing the precision and reliability of these monitoring systems. The integration of artificial intelligence and machine learning further augments the capabilities of IONM, making it indispensable in modern surgical practices. However, the high costs of implementation, limited reimbursement policies, and a shortage of skilled professionals pose significant challenges to market growth. Addressing these issues is essential to enhance accessibility and affordability of IONM. The impact of a global recession also presents a dual effect on the market. While economic constraints can limit healthcare budgets and reduce procedural volumes, the emphasis on cost-effective healthcare solutions can drive the adoption of IONM due to its preventive benefits, reducing the need for follow-up treatments. Technological advancements and strategic positioning will be crucial in overcoming these economic challenges.
The key regions considered for the global Intraoperative Neuromonitoring Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in 2023 and is expected to maintain its lead due to its advanced medical infrastructure and high incidence of chronic conditions. Meanwhile, Asia-Pacific is anticipated to exhibit the fastest growth during the forecast period, driven by the adoption of advanced IONM technologies and the prevalence of chronic diseases in the region. Furthermore, significant investments and the presence of key industry players are accelerating the growth of the intraoperative neuromonitoring market in Asia-Pacific.
Major market players included in this report are:
SpecialtyCare
Nihon Kohden Corporation
NuVasive, Inc.
Computational Diagnostics, Inc.
inomed Medizintechnik GmbH
NeuroStyle Pte. Ltd.
Intranerve Neuroscience Holdings, LLC
Accurate Monitoring
Medtronic plc
Natus Medical Incorporated

The detailed segments and sub-segment of the market are explained below:
By Products and Services
• Systems
• Accessories
• Services
By Source Type
• Insourced Monitoring
• Outsourced Monitoring
By Application
• Spinal Surgery
• Neurosurgery
• Orthopedic Surgery
• ENT Surgery
• Vascular Surgery
• Other surgeries
By Modality
• Motor evoked potentials (MEPs)
• Somatosensory evoked potentials (SSEPs)
• Electroencephalography (EEG)
• Electromyography (EMG)
• Brainstem auditory evoked potentials (BAEPs)
• Visual evoked potentials (VEPs)
By End User
• Hospitals
• Ambulatory Surgical Centers (ASCs)
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
• RoLA
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. Global Intraoperative Neuromonitoring market Executive Summary
1.1. Global Intraoperative Neuromonitoring market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Products and Services
1.3.2. By Source Type
1.3.3. By Application
1.3.4. By Modality
1.3.5. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Intraoperative Neuromonitoring market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Intraoperative Neuromonitoring market Dynamics
3.1. Market Drivers
3.1.1. Increasing Geriatric Population
3.1.2. Technological Advancements
3.1.3. Rising Prevalence of Target Diseases
3.2. Market Challenges
3.2.1. High Implementation Costs
3.2.2. Limited Reimbursement Policies
3.2.3. Shortage of Skilled Professionals
3.3. Market Opportunities
3.3.1. Integration of AI and Machine Learning
3.3.2. Growing Focus on Remote Patient Monitoring
3.3.3. Expansion in Emerging Markets

Chapter 4. Global Intraoperative Neuromonitoring market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Intraoperative Neuromonitoring market Size & Forecasts by Products and Services 2022-2032
5.1. Segment Dashboard
5.2. Global Intraoperative Neuromonitoring market: Products and Services Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Systems
5.2.2. Accessories
5.2.3. Services

Chapter 6. Global Intraoperative Neuromonitoring market Size & Forecasts by Source Type 2022-2032
6.1. Segment Dashboard
6.2. Global Intraoperative Neuromonitoring market: Source Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Insourced Monitoring
6.2.2. Outsourced Monitoring

Chapter 7. Global Intraoperative Neuromonitoring market Size & Forecasts by Application 2022-2032
7.1. Segment Dashboard
7.2. Global Intraoperative Neuromonitoring market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Spinal Surgery
7.2.2. Neurosurgery
7.2.3. Orthopedic Surgery
7.2.4. ENT Surgery
7.2.5. Vascular Surgery
7.2.6. Other surgeries

Chapter 8. Global Intraoperative Neuromonitoring market Size & Forecasts by Modality 2022-2032
8.1. Segment Dashboard
8.2. Global Intraoperative Neuromonitoring market: Modality Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Motor evoked potentials (MEPs)
8.2.2. Somatosensory evoked potentials (SSEPs)
8.2.3. Electroencephalography (EEG)
8.2.4. Electromyography (EMG)
8.2.5. Brainstem auditory evoked potentials (BAEPs)
8.2.6. Visual evoked potentials (VEPs)

Chapter 9. Global Intraoperative Neuromonitoring market Size & Forecasts by End User 2022-2032
9.1. Segment Dashboard
9.2. Global Intraoperative Neuromonitoring market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Hospitals
9.2.2. Ambulatory Surgical Centers (ASCs)

Chapter 10. Global Intraoperative Neuromonitoring market Size & Forecasts by Region 2022-2032
10.1. North America Intraoperative Neuromonitoring market
10.1.1. U.S. Intraoperative Neuromonitoring market
10.1.1.1. Products and Services breakdown size & forecasts, 2022-2032
10.1.1.2. Source Type breakdown size & forecasts, 2022-2032
10.1.1.3. Application breakdown size & forecasts, 2022-2032
10.1.1.4. Modality breakdown size & forecasts, 2022-2032
10.1.1.5. End User breakdown size & forecasts, 2022-2032
10.1.2. Canada Intraoperative Neuromonitoring market
10.2. Europe Intraoperative Neuromonitoring market
10.2.1. U.K. Intraoperative Neuromonitoring market
10.2.2. Germany Intraoperative Neuromonitoring market
10.2.3. France Intraoperative Neuromonitoring market
10.2.4. Spain Intraoperative Neuromonitoring market
10.2.5. Italy Intraoperative Neuromonitoring market
10.2.6. Rest of Europe Intraoperative Neuromonitoring market
10.3. Asia-Pacific Intraoperative Neuromonitoring market
10.3.1. China Intraoperative Neuromonitoring market
10.3.2. India Intraoperative Neuromonitoring market
10.3.3. Japan Intraoperative Neuromonitoring market
10.3.4. Australia Intraoperative Neuromonitoring market
10.3.5. South Korea Intraoperative Neuromonitoring market
10.3.6. Rest of Asia Pacific Intraoperative Neuromonitoring market
10.4. Latin America Intraoperative Neuromonitoring market
10.4.1. Brazil Intraoperative Neuromonitoring market
10.4.2. Mexico Intraoperative Neuromonitoring market
10.4.3. Rest of Latin America Intraoperative Neuromonitoring market
10.5. Middle East & Africa Intraoperative Neuromonitoring market
10.5.1. Saudi Arabia Intraoperative Neuromonitoring market
10.5.2. South Africa Intraoperative Neuromonitoring market
10.5.3. Rest of Middle East & Africa Intraoperative Neuromonitoring market

Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Company 1
11.1.2. Company 2
11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. NuVasive, Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Computational Diagnostics, Inc.
11.3.3. inomed Medizintechnik GmbH
11.3.4. NeuroStyle Pte. Ltd.
11.3.5. Intranerve Neuroscience Holdings, LLC
11.3.6. Accurate Monitoring
11.3.7. Natus Medical Incorporated
11.3.8. SpecialtyCare
11.3.9. Nihon Kohden Corporation
11.3.10. Medtronic plc



Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes